| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |